Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Chicago, Illinois 60611


Purpose:

The purpose of this study is to compare the effectiveness of two methods in the treatment of excessive underarm sweating (axillary hyperhidrosis): suction-curettage and Botox injections. Suction-curettage is a method in which the doctor will insert a suction tool into two small incisions in order to suction out the sweat-producing glands. It is similar to liposuction, but instead of suctioning out fat, the doctor suctions out the layer of the deep skin where the sweat glands are located. This method has been shown in some studies to effectively reduce underarm sweating for months at a time. Botox is a Food and Drug Administration (FDA) approved drug that in small doses, paralyses muscles. It is most commonly and famously used in the treatment of facial wrinkles. However, it has also been approved to treat excessive sweating. When injected in areas that sweat excessively, sweating can be significantly reduced in that area for months at a time. This study is a pilot study designed to determine feasibility of these procedures.


Criteria:

Inclusion Criteria: - Ages 18 to 65 - BMI 18.5 - 29.99 - Diagnosis of bilateral axillary hyperhidrosis refractory to previous topical therapies - Subject is in good health - Subject has the willingness and ability to understand and provide informed consent Exclusion Criteria: - Under age 18 or over age 65 - Pregnancy or lactating - BMI ≥ 30 or ≤18.4 - Subjects who have undergone axillary suction/curettage any time in the past - Subjects who have undergone axillary BT-A injections in the past year - Subjects currently taking blood thinners or who have had chemotherapy or radiation within the last 6 months - Subjects with a history of a bleeding disorder - Subjects with an open, non-healing sore or infection near site of procedure - Subjects with allergies to iodine, starch powder, albumin, or any botulinum toxin product


NCT ID:

NCT01274611


Primary Contact:

Principal Investigator
Murad Alam, MD
Northwestern University


Backup Contact:

N/A


Location Contact:

Chicago, Illinois 60611
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.